News

2022-01-01

MediMabBio selected as the ‘Best Employer’ by Seongnam City Council

2021-10-28

MediMabBio takes first step towards commercialization with Thermo Fisher CDMO Contract

2021-06-28

MediMabBio has made a collaboration deal with University Hospitals Birmingham for immunotherapy cancer drug development

2021-02-15

MediMabBio has successfully completed a Series-A fundraising with 18 million USD

2020-05-27

MediMabBio establishes UK Subsidiary, MediMab Biotherapeutics

2019-02-19

MediMabBio Secures $3 Million Investment to Advance “New-Generation Cancer Treatment”

2017-07-26

MediMabBio Chosen for Up to $1 Million Funding from the TIPS Program